OGI · NASDAQ · Drug Manufacturers - Specialty & Generic

Organigram Global (OGI)

Produces indoor-grown cannabis for Canadian patients and adult-use consumers under a multi-brand portfolio.

$1.12
After hours−0.00 (−0.30%)
At close$1.12(0.00%)

In millions of USD, except per-share figures · converted from CAD at the latest rate

In millionsQ4 FY23Sep 2023Q1 FY24Dec 2023Q2 FY24Mar 2024Q3 FY24Jun 2024Q4 FY24Sep 2024Q1 FY25Dec 2024Q2 FY25Mar 2025Q3 FY25Jun 2025Q4 FY25Sep 2025Q1 FY26Dec 2025Q2 FY26Mar 2026Q3 FY26Jun 2026
Revenue332627293230475057454375
Cost of revenue422120192021343234293146
Gross profit−957101210131923171229
191618141215182022191926
Research & development332212222112
161215111012151718161624
Selling & marketing034434566669
General & administrative091177810101210915
Other expenses011111222220
Operating income−28−11−11−40−5−5−11−2−74
30−96−4−1136−10−3117670
Interest income100000000000
Interest expense000000000000
Other non-operating income−300−6−30000000
Income before tax−25−11−192−4−1630−12−3014−174
Income tax expense−2000000−7−300−1
Net income from continuing operations−23−11−192−4−1630−4−2714−175
Net income−23−11−192−4−1630−4−2714−175
EPS, basic−$0.29−$0.14−$0.21$0.02−$0.06−$0.14$0.23−$0.03−$0.20$0.11−$0.00$0.55
EPS, diluted−$0.29−$0.14−$0.21$0.02−$0.06−$0.14$0.23−$0.03−$0.20$0.11−$0.00$0.55
Weighted average shares, basic81819110469114129134134135132137
Weighted average shares, diluted81819110869114134134134137132137
EBITDA−21−9−945−2−2241−311
Depreciation & amortization422222334448
EBIT−25−11−1123−5−5−11−2−74